Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Capmatinib is highly selective for c-Met targets, can effectively inhibit the pr···【more】
Release date：2024-08-07Recommended：262
Capmatinib prevents the growth and spread of cancer cells by inhibiting MET tyro···【more】
Release date：2024-08-06Recommended：352
Capmatinib is a targeted therapy for patients with non-small cell lung cancer wi···【more】
Release date：2024-08-06Recommended：340
Capmatinib is an oral drug manufactured by Novartis Pharmaceutical. It is a tyro···【more】
Release date：2024-08-06Recommended：287
Capmatinib inhibits the growth of cancer cells caused by specific genetic varian···【more】
Release date：2024-08-06Recommended：337
The price of Exkivity varies depending on a number of factors, including the ver···【more】
Release date：2024-08-06Recommended：257
Exkivity is an orally targeted drug targeting EGFR gene mutations for the treatm···【more】
Release date：2024-08-06Recommended：284
Exkivity is a targeted therapy for specific types of non-small cell lung cancer ···【more】
Release date：2024-08-06Recommended：273
Exkivity is a targeted drug for the treatment of specific types of lung cancer, ···【more】
Release date：2024-08-06Recommended：337
Exkivity is available in multiple versions, including innovator versions and mul···【more】
Release date：2024-08-06Recommended：296
Exkivity, also known as Mobocertinib, is a novel targeted drug that offers hope ···【more】
Release date：2024-08-06Recommended：341
Capmatinib inhibits MET phosphorylation by hepatocyte growth factor binding or t···【more】
Release date：2024-08-06Recommended：228
